You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pegfilgrastim

Showing 1 - 25 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloma Multiple, Lymphoma Trial in Monterrey (Pegfilgrastim)

Recruiting
  • Myeloma Multiple
  • Lymphoma
  • Pegfilgrastim
  • Monterrey, Nuevo León, Mexico
    Hospital Universitario Dr. José Eleuterio González
Apr 18, 2022

Quality and Quantity of M-PRP Cellular Content Filgrastim vs.

Recruiting
  • Healthy
  • Gulf Breeze, Florida
    Andrews Research and Education Foundation
Oct 6, 2022

Neutropenia Trial in Beijing (Pegfilgrastim)

Completed
  • Neutropenia
  • Pegfilgrastim
  • Beijing, Beijing, China
    Department of Medical Oncology
Mar 12, 2022

HER2-positive Breast Cancer, Operable Breast Cancer Trial in France (Trastuzumab + Paclitaxel, Pegfilgrastim)

Recruiting
  • HER2-positive Breast Cancer
  • Operable Breast Cancer
  • Trastuzumab + Paclitaxel
  • Pegfilgrastim
  • Avignon, France
  • +8 more
Jan 9, 2023

Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

Recruiting
  • Aplastic Anemia
  • +3 more
  • Anti-Thymocyte Globulin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2021

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Early-stage Breast Cancer Trial in Ottawa (Filgrastim, Pegfilgrastim)

Recruiting
  • Early-stage Breast Cancer
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute
Jun 10, 2021

Lymphoma Trial (pegfilgrastim, rituximab, cyclophosphamide)

Completed
  • Lymphoma
  • pegfilgrastim
  • +5 more
  • (no location specified)
Jul 2, 2021

Ann Arbor Stage II DLBCL, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma Trial in Scottsdale,

Recruiting
  • Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
  • +13 more
  • Scottsdale, Arizona
  • +2 more
Jun 1, 2022

Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,

Recruiting
  • Stage II Bladder Cancer AJCC v8
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 12, 2022

Breast Cancer Trial (Niraparib, Doxorubicin, Cyclophosphamide)

Withdrawn
  • Breast Cancer
  • (no location specified)
Apr 20, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Luveltamab tazevibulin
  • Pegfilgrastim
  • (no location specified)
May 12, 2023

Medulloblastoma Trial in Memphis (procedure, drug, radiation)

Recruiting
  • Medulloblastoma
  • Surgical resection
  • +11 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Sep 16, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • FOR46
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 1, 2022

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
Has Results
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Neuroendocrine Tumors, Tumors, Cancer Trial in Madison (TAS-102, Temozolomide, Filgrastim)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Oct 29, 2021

Breast Cancer Trial in Canada (pegfilgrastim, docetaxel, epirubicin HCl)

Completed
  • Breast Cancer
  • pegfilgrastim
  • +2 more
  • Winnipeg, Manitoba, Canada
  • +4 more
Nov 6, 2020

Sarcoma Trial in Baltimore, Minneapolis (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • pegfilgrastim
  • +5 more
  • Baltimore, Maryland
  • +1 more
Mar 25, 2022

Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma, Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 21, 2022

Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia Trial in Germany, Italy, Spain

Completed
  • Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
  • Aurich, Germany
  • +59 more
Jun 6, 2022

Peripheral Blood Stem Cell Transplantation Trial in Sapporo (Pegfilgrastim)

Completed
  • Peripheral Blood Stem Cell Transplantation
  • Pegfilgrastim
  • Sapporo, Hokkaido, Japan
    Hokkaido University Hospital
Jan 20, 2021

Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)

Active, not recruiting
  • Multiple Myeloma
  • Amyloidosis
  • Melphalan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022